Arcus Biosciences Inc (NYSE:RCUS)
$ 24.59 -1.56 (-5.97%) Market Cap: 3.13 Bil Enterprise Value: 2.54 Bil PE Ratio: 0 PB Ratio: 6.73 GF Score: 44/100

Arcus Biosciences Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 11:00PM GMT
Release Date Price: $24.56 (+8.00%)
Matthew Bannon
JPMorgan Chase & Co - Analyst

Okay. Welcome back to the 44th Annual JPMorgan Healthcare Conference. My name is Matt Bannon. I'm a banker here at JPM.

I'm very pleased to be introducing our next presenting company of the day, Arcus Biosciences. And on behalf of Arcus, we have the CEO, Terry Rosen.

Before we kick things off, I'll just remind folks that we will have a Q&A session. So just raise your hand, we'll get you a mic or you can ask it through the online portal, and I'll relay it on your behalf.

So without further ado, Terry?

Terry Rosen
Arcus Biosciences Inc - Chairman of the Board, Chief Executive Officer, Co-Founder

Thanks. So good afternoon, everybody. Many of you are probably very familiar with Arcus and followed us for a long time, but hopefully, there's some new people, so what we thought we would do is start with a very brief overview of the company.

Arcus was founded about 10 years ago with basically a blank piece of paper with the notion of building an extraordinary small molecule

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot